Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.32 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
| ▸ | JAK1 | P23458 | 1/20 | 0.31 |
| ▸ | TYK2 | P29597 | 1/20 | 0.31 |
| ▸ | JAK3 | P52333 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | FLT3 | P36888 | 1/20 | 0.31 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.31 |
| ▸ | TDO2 | P48775 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29209720 | 0.75 | TDO2 (0.45) | NOS1TRPA1JAK2JAK1TYK2 | |
| SCHEMBL21128195 | 0.72 | NOS1 (0.40) | NOS1HTTPTK2 | |
| SCHEMBL31599741 | 0.70 | TRPA1 (0.40) | NOS1TRPA1JAK2JAK1TYK2 | |
| SCHEMBL31092002 | 0.69 | HSP90AA1 (0.43) | JAK2JAK1TYK2JAK3TDO2 | |
| SCHEMBL28741988 | 0.69 | HSP90AA1 (0.43) | JAK2JAK1TYK2JAK3TDO2 | |
| SCHEMBL26107758 | 0.69 | NOS1 (0.34) | NOS1HTTPTK2 | |
| SCHEMBL29209798 | 0.69 | TRPA1 (0.39) | NOS1TRPA1JAK2JAK1TYK2 | |
| SCHEMBL30540635 | 0.69 | NOS1 (0.34) | NOS1HTTPTK2 | |
| SCHEMBL28502698 | 0.68 | TDO2 (0.45) | NOS1TRPA1JAK2JAK1TYK2 | |
| SCHEMBL30540461 | 0.68 | NOS1 (0.33) | NOS1HTTPTK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017220431-A1 | FUSED PYRAZOLE DERIVATIVES AS JAK INHIBITORS | ALMIRALL, S.A. (ES) | 2017-12-28 | — | — | WO | disclosed |